Literature DB >> 1639471

Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.

W Byrd1, S Kadis.   

Abstract

Conjugate vaccines were prepared in an attempt to protect pigs against swine pleuropneumonia induced by Actinobacillus pleuropneumoniae (SPAP). Two subunit conjugates were prepared by coupling the A. pleuropneumoniae 4074 serotype 1 capsular polysaccharide (CP) to the hemolysin protein (HP) and the lipopolysaccharide (LPS) to the HP. Adipic acid dihydrazide was used as a spacer to facilitate the conjugation in a carbodiimide-mediated reaction. The CP and the LPS were found to be covalently coupled to the HP in the conjugates as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and detergent gel chromatography analyses. Following a booster vaccination, pigs exhibited significantly high (P less than 0.05) immunoglobulin G antibodies against CP, LPS, and HP. The anti-CP and anti-LPS immunoglobulin G antibodies were found to function as opsonins in the phagocytosis of A. pleuropneumoniae by polymorphonuclear leukocytes, whereas antibodies to the HP neutralized the cytotoxic effect of the HP on polymorphonuclear leukocytes. No killing of A. pleuropneumoniae was observed when the effects of the antibodies were tested in the presence of complement. Thus, polysaccharide-protein A. pleuropneumoniae conjugates elicit significant antibody responses against each component of each conjugate, which could be instrumental in protecting swine against SPAP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639471      PMCID: PMC257279          DOI: 10.1128/iai.60.8.3042-3051.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Haemophilus pleuropneumoniae infection in swine: a review.

Authors:  T N Sebunya; J R Saunders
Journal:  J Am Vet Med Assoc       Date:  1983-06-15       Impact factor: 1.936

3.  Purification, characterization and immunological properties of the serotype-specific capsular polysaccharide of Pasteurella haemolytica (serotype A1) organisms.

Authors:  C Adlam; J M Knights; A Mugridge; J C Lindon; P R Baker; J E Beesley; B Spacey; G R Craig; L K Nagy
Journal:  J Gen Microbiol       Date:  1984-09

Review 4.  The antimicrobial role of the neutrophil leukocyte.

Authors:  A W Segal
Journal:  J Infect       Date:  1981-03       Impact factor: 6.072

5.  Porcine Haemophilus pleuropneumonia epizootic in southwestern Ontario: clinical, microbiological, pathological and some epidemiological findings.

Authors:  S E Sanford; G K Josephson
Journal:  Can J Comp Med       Date:  1981-01

6.  Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.

Authors:  H J Jennings; C Lugowski; F E Ashton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  The serological properties of the cell surface proteins of Vibrio cholerae.

Authors:  S Kabir
Journal:  J Gen Microbiol       Date:  1983-07

8.  Quantitative morphology of peracute pulmonary lesions in swine induced by Haemophilus pleuropneumoniae.

Authors:  T A Bertram
Journal:  Vet Pathol       Date:  1985-11       Impact factor: 2.221

9.  An enzyme-linked immunosorbent assay, using an EDTA-extracted antigen for the serology of Haemophilus pleuropneumoniae.

Authors:  J Nicolet; P Paroz; M Krawinkler; A Baumgartner
Journal:  Am J Vet Res       Date:  1981-12       Impact factor: 1.156

10.  Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.

Authors:  R P Darveau; R E Hancock
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

View more
  10 in total

1.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Experimental vaccination of pigs with an Actinobacillus pleuropneumoniae serotype 5b capsular polysaccharide-tetanus toxoid conjugate.

Authors:  L O Andresen; M J Jacobsen; J P Nielsen
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

3.  Genomic relatedness among Actinobacillus pleuropneumoniae field strains of sterotypes 1 and 5 isolated from healthy and diseased pigs.

Authors:  S Chatellier; J Harel; D Dugourd; B Chevallier; M Kobisch; M Gottschalk
Journal:  Can J Vet Res       Date:  1999-07       Impact factor: 1.310

4.  An enzyme-based protocol for cell-free synthesis of nature-identical capsular oligosaccharides from Actinobacillus pleuropneumoniae serotype 1.

Authors:  Insa Budde; Christa Litschko; Jana I Führing; Rita Gerardy-Schahn; Mario Schubert; Timm Fiebig
Journal:  J Biol Chem       Date:  2020-03-09       Impact factor: 5.157

5.  Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.

Authors:  A Hensel; R Pabst; S Bunka; K Petzoldt
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

6.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

7.  A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens.

Authors:  Christa Litschko; Davide Oldrini; Insa Budde; Monika Berger; Jochen Meens; Rita Gerardy-Schahn; Francesco Berti; Mario Schubert; Timm Fiebig
Journal:  mBio       Date:  2018-05-29       Impact factor: 7.867

8.  Mix-and-Match System for the Enzymatic Synthesis of Enantiopure Glycerol-3-Phosphate-Containing Capsule Polymer Backbones from Actinobacillus pleuropneumoniae, Neisseria meningitidis, and Bibersteinia trehalosi.

Authors:  Christa Litschko; Insa Budde; Monika Berger; Andrea Bethe; Julia Schulze; E Alberto Alcala Orozco; Reza Mahour; Peter Goettig; Jana Indra Führing; Thomas Rexer; Rita Gerardy-Schahn; Mario Schubert; Timm Fiebig
Journal:  mBio       Date:  2021-05-26       Impact factor: 7.867

9.  Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.

Authors:  Ian J Passmore; Anna Andrejeva; Brendan W Wren; Jon Cuccui
Journal:  BMC Vet Res       Date:  2019-01-03       Impact factor: 2.741

Review 10.  Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.

Authors:  Jon Cuccui; Brendan Wren
Journal:  J Pharm Pharmacol       Date:  2014-09-22       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.